An Artificial Intelligence technology shows promise in predicting the danger of pulmonary nodule cancer | Technology

An Artificial Intelligence technology shows promise in predicting the danger of pulmonary nodule cancer | Technology
An Artificial Intelligence technology shows promise in predicting the danger of pulmonary nodule cancer

Artificial Intelligence tool shows promise in identifying lung nodule cancer risk

The new artificial intelligence program is another example of how new computer technologies can benefit doctors in treating patients.

As artificial intelligence and machine learning technologies continue to develop, they can become powerful tools in many fields, including medicine. 

AI, which complements human experience and judgment, has already shown promise as a forecasting tool. Recent research using an artificial intelligence program to help identify lung cancer risk from the results of chest scans is an example of the technique in action.

Lung cancer is the second most common form of cancer worldwide, according to the World Cancer Research Fund. In Australia, it is the leading cause of cancer deaths and Cancer Australia estimates that lung cancer accounted for 17.7% of all cancer deaths in 2021.

READ MORE: Artificial Intelligence will make Indian roadways safer to travel on | Technology

Computed tomography (CT) is a type of three-dimensional image that is often used in the detection and diagnosis of cancer. Small abnormal areas, called pulmonary nodules, are sometimes found on chest CT scans. Most lung nodules seen on scans are not cancer, but some may be at risk of becoming cancerous growths. A key part of cancer detection is determining from chest scans the likelihood of cancer developing from lung nodules.

A new study, published today in the journal Radiology, presents a diagnostic AI computer tool.

Study lead author Anil Vachani, director of clinical research in the section of Interventional Pulmonology and Thoracic Oncology at the University of Pennsylvania Perelman School of Medicine in Philadelphia, USA, says CT scans are more favored than x-rays for chest imaging.

READ MORE: The use of Augmented Reality in Real Estate is no longer a gimmick | Technology

“A nodule would show up somewhere between 5% and 8% of chest X-rays. The chest CT scan is such a sensitive test that you will see a small nodule in more than one-third to one-half of cases. We've gone from a problem that was relatively rare to one that affects 1.6 million people in the US each year,” says Vachani.

Vachani's team used the AI ​​diagnostic tool developed by Oxford, UK-based Optellum Ltd., to help doctors assess lung nodules found on CT scans. AI, they argue, can go beyond the basics of a nodule, such as size and edge characteristics.

“AI can analyze very large data sets to generate unique patterns that cannot be seen with the naked eye and that end up predicting malignancy,” says Vachani.

READ MORE: 5 AI Growth Stocks To Buy & Hold | Technology and Business 

The researchers provided six pulmonologists and six radiologists with CT imaging data from 300 scans of indeterminate lung nodules (those between 5 and 30 millimeters in diameter) to estimate the risk of malignancy. The experts were also asked to make management recommendations, such as CT checks or additional diagnostic procedures. They were asked to do this with and without the help of the AI ​​tool.

Analysis of expert responses showed that the AI ​​tool improved nodule malignancy risk estimation and physician agreement, both in risk stratification and patient management strategies.

“Readers judge malignant or benign with a reasonable level of accuracy based on the images themselves, but when you combine their clinical interpretation with the AI ​​algorithm, the level of accuracy improves significantly,” says Vachani.

READ MORE: Virtual Reality techniques for stroke therapy show promise | Technology

"The level of improvement suggests that this tool has the potential to change the way we judge cancer versus benign and hopefully improve the way we manage patients."

The study is a further step in the use of artificial intelligence in medicine. But more research is needed before the tool can be used to test real patients in the clinic, says Vachani

“We took the first step here and showed that decision making is better if the AI ​​tool is incorporated into the radiology or pulmonology practice,” she says. “The next step is to take the tool and run some prospective trials where clinicians use the AI ​​tool in a real-world setting. We are in the process of designing those trials.”

Source: Cosmos Magazine, Direct News 99